BMGL — Basel Medical Share Price
Last trade - 00:00- $79.91m
- $81.62m
- SG$10.05m
- 70
- 15
- 42
- 37
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 13.9 | ||
| Price to Tang. Book | 13.9 | ||
| Price to Free Cashflow | 42.01 | ||
| Price to Sales | 10.46 | ||
| EV to EBITDA | 24.1 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 48.37% | ||
| Return on Equity | 31.77% | ||
| Operating Margin | 44.01% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | n/a | n/a | 10.66 | 9.7 | 10.05 | n/a | n/a | -2.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -9.84 | +16.24 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Singmed Specialists Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, and more. Its services include orthopedic treatments and surgery, rehabilitative therapy, and neurosurgical care. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments to complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- August 10th, 2023
- Public Since
- February 25th, 2025
- No. of Employees
- 36
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 18,455,000
- Address
- 600 North Bridge Road, 188778
- Web
- https://www.baselmedical.com
- Phone
- +65 62919188
- Auditors
- Audit OneStop Assurance PAC
Similar to BMGL
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
BRK International Holding
NASDAQ Capital Market
FAQ
As of Today at 19:30 UTC, shares in Basel Medical are trading at $4.33. This share price information is delayed by 15 minutes.
Shares in Basel Medical last closed at $4.33 and the price had moved by over the past 365 days. In terms of relative price strength the Basel Medical share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreBasel Medical does not currently pay a dividend.
Basel Medical does not currently pay a dividend.
Basel Medical does not currently pay a dividend.
To buy shares in Basel Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.33, shares in Basel Medical had a market capitalisation of $79.91m.
Here are the trading details for Basel Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: BMGL
Based on an overall assessment of its quality, value and momentum Basel Medical is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Basel Medical. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $4.33, shares in Basel Medical were trading -1.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Basel Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Basel Medical's directors